Geisinger nurse to tell powerful personal story of how epidemic affected her family
DANVILLE, Pa. – Geisinger is joining other national health care leaders to develop innovative ways that technology and data can be used to address the nationwide opioid epidemic. The latest innovations will be the subject of an Opioid Symposium and Code-a-Thon hosted by the U.S. Department of Health & Human Services in Washington, D.C. The symposium will be held on December 6-7.
A Geisinger post-anesthesia care unit (PACU) nurse, who lost her 23-year-old daughter to heroin addiction, will also speak at the event to share her powerful personal story.
Bridget Farrell’s daughter Delaney died from an overdose this past summer. Before her death, Delaney wrote an emotional poem about her addiction. Bridget decided to include the poem in her daughter’s obituary which received attention all over the country. “I want people to understand the struggle of Delaney and our family,” said Bridget. “Most importantly, I want them to see who she was. This beautiful, vibrant girl.”
Since 2014, Geisinger has reduced opioid prescriptions in emergency departments, physician offices and community practice clinics by almost half, from an average of 60,000 prescriptions per month to 31,000. The dramatic decrease in prescribing opioids is the result of the health system’s proactive team approach to managing chronic pain and using several different treatment options to address patients who are addicted to opioids or may be at-risk for addiction.
“At Geisinger, we wage the battle on multiple fronts every day,” said Dr. David T. Feinberg, M.D., Geisinger President and CEO. “We’ve worked to combat this epidemic for many years, and we’ll continue to study, innovate and share our results with other communities until we can all declare victory over this crisis.”
Geisinger is an integrated health services organization widely recognized for its innovative use of the electronic health record and the development of innovative care delivery models such as ProvenHealth Navigator®, ProvenCare® and ProvenExperience®. As one of the nation’s largest health service organizations, Geisinger serves more than 3 million residents throughout 45 counties in central, south-central and northeast Pennsylvania, and also in southern New Jersey at AtlantiCare, a Malcolm Baldrige National Quality Award recipient. In 2017, the Geisinger Commonwealth School of Medicine and Geisinger Jersey Shore Hospital became the newest members of the Geisinger Family. The physician-led system is comprised of approximately 30,000 employees, including nearly 1,600 employed physicians, 13 hospital campuses, two research centers, and a 583,000-member health plan, all of which leverage an estimated $12.7 billion positive impact on the Pennsylvania and New Jersey economies. Geisinger has repeatedly garnered national accolades for integration, quality and service. In addition to fulfilling its patient care mission, Geisinger has a long-standing commitment to medical education, research and community service. For more information, visit www.geisinger.org, or connect with us on Facebook, Instagram, LinkedIn and Twitter.
For media inquiries: